ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP09

The Role of a Palliative Care Support Team to Optimize Outcomes for Patients with Airway Involvement from Relapsing Polychondritis

Joshua Sparks

Meeting: ACR Convergence 2025

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (PP09-PP13) Patient Perspectives

Session Type: Patient Perspectives

Session Time: 8:15AM-8:30AM

Background/Purpose: Relapsing polychondritis (RP) is an inflammatory condition with a variable phenotype thought to be due to autoimmunity towards cartilage, particularly, that found in the airway.  It can be challenging to diagnose and lead to symptoms that can have a profound effect on quality of life (QOL) and is one of the leading causes of morbidity and mortality for this condition.  I was diagnosed with RP after over a decade with “challenging asthma.”  In addition to progressive diffuse airway malacia (figure 1), I had auricular chondritis, migratory polyarthritis, episcleritis, and sicca syndrome.  After an extended period of steroids and multiple medications, partial remission was achieved with low dose prednisone, IV tocilizumab, methotrexate, and hydroxychloroquine.  Despite adequate immune control, the residual airway damage resulted in nearly constant air hunger, dyspnea, and cough.  After 1 year, I was barely able to walk, talk, or work requiring intermittent positive airway pressure (PAP) and cough suppressants during the day.

Intervention:

Once on immunotherapy, the persistent air hunger led to poor mental health and fear.  As a physician involved in the care of very complex diseases, I work alongside palliative care (PC) teams, and I thought they might be able to help.  Against the advice of my primary doctor, I sought consultation with my local PC program.  After assessment, we worked to establish goals and a plan.; specifically, time free from air hunger, reduced cough, and to be able to continue working. 

Maintenance:

Unfortunately, things were more complicated than I was prepared for which led to the first and most important intervention:  acknowledging the severity of my illness.  In addition to the airway symptoms, I was obese with low muscle mass from steroids and the situation was untenable.  Working was unrealistic, especially in my chosen career, and continuing likely increased risk of complications and death.  I was totally disabled.  Step one, I had to quit working.  Next, though I was skeptical, I start extended release morphine for air hunger.  Despite my skepticism, this proved to be highly effective and I was able to breathe comfortably resulting in an immediate and significant improvement in my QOL. 

Quality of Life:

After an adjustment period, I began trauma and grief counseling and refocused on my QOL with the goal to get back to work.  I began moving some every day.  This wasn’t simple or easy requiring mobility aids and portable PAP (See figure 2).  Over time, I was able to take walks and travel.  After 2+ years, I lost 125 lbs and increased my strength (See figure 3).  After 4 years, I was finally able to go back to work.  I have kept off the weight and have strategies in place to focus on living day to day.  Without PC’s unique expertise directing focus toward goals and QOL, I would be more likely to be a statistic than writing this abstract.

Takeaway:

In conclusion, airway involvement from RP leads to symptoms of severe cough, dyspnea, and air hunger compounded by the debilitating effects of steroids.  These symptoms are complex and challenging and can persist despite remission of the disease.  PC provides unique expertise in the treatment of respiratory symptoms and poor QOL commonly found in advanced stages of disease.  Though traditionally associated with the end of life, when a PC team is utilized to focus on a patient’s symptom control and QOL, it can help to optimize rehabilitation and maintenance of overall health thereby improving outcomes for patients with advanced airway involvement from RP.


Disclosures: J. Sparks: None

To cite this abstract in AMA style:

Sparks J. The Role of a Palliative Care Support Team to Optimize Outcomes for Patients with Airway Involvement from Relapsing Polychondritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-role-of-a-palliative-care-support-team-to-optimize-outcomes-for-patients-with-airway-involvement-from-relapsing-polychondritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-a-palliative-care-support-team-to-optimize-outcomes-for-patients-with-airway-involvement-from-relapsing-polychondritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology